Endometrial cancer mainly occurs in postmenopausal women, with the incidence significantly increasing with age. Treatment methods are diverse, covering surgery, radiotherapy, chemotherapy, and emerging immune reconstruction cell therapy. Missing the optimal treatment window may cause the condition to deteriorate rapidly, affecting prognosis and increasing the risk of recurrence and metastasis.
As a new treatment approach, immune reconstruction cell therapy activates the patient’s own immune system to precisely kill tumor cells, effectively reducing recurrence risk and promoting immune system recovery.
① Activate patient immune cells to enhance anti-tumor response;
② Regulate the immune microenvironment to reduce tumor immune evasion;
③ Combine with traditional treatments to improve overall efficacy and tolerance.
In clinical practice, tumor patients undergoing surgery, radiotherapy, and chemotherapy often face immune function impairment, increased infection risks, and slow recovery. To support patients through treatment, improve tolerance, and enhance survival quality, it is necessary to scientifically formulate immune reconstruction plans tailored to different treatment cycles.
● Short-term plan: Rapidly enhance immunity through immune cell reinfusion to strengthen anti-tumor treatment effects.
● Mid-term plan: Reduce side effects of conventional treatments, promote recovery, and help complete standardized therapy.
● Long-term plan: Improve overall immunity through immune cell reconstruction, gut immunity rebuilding, elemental immunity rebuilding, and immune nutrition rebuilding, thereby improving quality of life and extending survival.
1. Surgical treatment
Surgery is the cornerstone of endometrial cancer treatment, mainly including total hysterectomy and bilateral salpingo-oophorectomy. The surgical scope is determined by pathological staging and tumor invasion depth, aiming to completely remove tumor tissue and prevent recurrence.
2. Radiotherapy
Radiotherapy is used as adjuvant therapy after surgery or for inoperable patients. It employs high-energy rays to destroy cancer cells, shrink tumors, and control local lesions. Combining external beam radiation with brachytherapy improves treatment precision.
3. Chemotherapy
Chemotherapy is applied for advanced or metastatic endometrial cancer patients. It uses drugs to inhibit cancer cell proliferation and slow disease progression. Common drugs include platinum agents and paclitaxel. Side effects require close monitoring and management.
4. Minimally invasive treatment methods
With technological advancement, minimally invasive surgeries such as laparoscopy and robot-assisted surgery are widely used. They cause less trauma, enable faster recovery, and reduce postoperative complications. For early-stage patients, minimally invasive surgery provides both effectiveness and safety.
5. Endocrine therapy
For patients with hormone receptor-positive tumors, endocrine therapy can be chosen to inhibit tumor growth by regulating hormone levels. It is suitable for those who are not candidates for surgery or chemotherapy.
6. Targeted therapy
Targeted drugs intervene in pathological processes by acting on tumor-specific molecules. They are one of the important treatment options for advanced patients.
The treatment of endometrial cancer requires a combination of multiple approaches. Immune reconstruction cell therapy, as an innovative method, shows promising prospects. Experts at United Life International Medical Center emphasize that early diagnosis and standardized treatment are key to ensuring quality of life and extending survival. Patients should actively cooperate with treatment, undergo regular follow-ups, and prevent recurrence.